NORTHERN TRUST CORP - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 164 filers reported holding ANIKA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,728,494
-34.2%
146,457
-8.2%
0.00%0.0%
Q2 2023$4,146,694
-9.8%
159,611
-0.3%
0.00%0.0%
Q1 2023$4,597,900
-2.9%
160,094
+0.1%
0.00%0.0%
Q4 2022$4,733,839
+18.9%
159,927
-4.4%
0.00%0.0%
Q3 2022$3,982,000
+3.5%
167,305
-3.0%
0.00%0.0%
Q2 2022$3,847,000
-16.9%
172,419
-6.5%
0.00%0.0%
Q1 2022$4,631,000
-38.1%
184,381
-11.6%
0.00%0.0%
Q4 2021$7,476,000
-19.4%
208,628
-4.3%
0.00%
-50.0%
Q3 2021$9,277,000
-2.2%
217,962
-0.6%
0.00%0.0%
Q2 2021$9,489,000
+20.5%
219,202
+13.5%
0.00%
+100.0%
Q1 2021$7,876,000
-24.3%
193,084
-16.0%
0.00%
-50.0%
Q4 2020$10,399,000
+22.8%
229,759
-4.0%
0.00%0.0%
Q3 2020$8,468,000
-9.1%
239,279
-3.1%
0.00%0.0%
Q2 2020$9,314,000
+68.4%
246,837
+29.0%
0.00%0.0%
Q1 2020$5,530,000
-44.5%
191,297
-0.4%
0.00%0.0%
Q4 2019$9,957,000
-7.4%
192,054
-2.0%
0.00%
-33.3%
Q3 2019$10,758,000
+34.6%
196,009
-0.4%
0.00%
+50.0%
Q2 2019$7,995,000
+36.8%
196,841
+1.8%
0.00%
+100.0%
Q1 2019$5,845,000
-10.2%
193,299
-0.2%
0.00%
-50.0%
Q4 2018$6,508,000
-22.0%
193,606
-2.1%
0.00%0.0%
Q3 2018$8,343,000
+32.1%
197,806
+0.2%
0.00%0.0%
Q2 2018$6,316,000
-36.3%
197,347
-1.0%
0.00%
-33.3%
Q1 2018$9,915,000
-7.8%
199,422
+0.0%
0.00%0.0%
Q4 2017$10,750,000
-6.9%
199,413
+0.2%
0.00%0.0%
Q3 2017$11,541,000
+15.1%
198,987
-2.1%
0.00%0.0%
Q2 2017$10,029,000
+18.4%
203,260
+4.2%
0.00%
+50.0%
Q1 2017$8,474,000
-7.9%
195,071
+3.8%
0.00%
-33.3%
Q4 2016$9,201,000
+4.2%
187,943
+1.9%
0.00%0.0%
Q3 2016$8,828,000
-10.7%
184,499
+0.1%
0.00%0.0%
Q2 2016$9,891,000
+17.0%
184,355
-2.5%
0.00%0.0%
Q1 2016$8,453,000
+18.3%
189,026
+0.9%
0.00%
+50.0%
Q4 2015$7,145,000
+24.7%
187,258
+4.0%
0.00%0.0%
Q3 2015$5,729,000
-3.6%
180,018
+0.1%
0.00%0.0%
Q2 2015$5,942,000
-19.9%
179,919
-0.2%
0.00%0.0%
Q1 2015$7,420,000
+1.5%
180,220
+0.5%
0.00%0.0%
Q4 2014$7,309,000
+8.3%
179,411
-2.5%
0.00%0.0%
Q3 2014$6,748,000
-10.0%
184,066
+13.8%
0.00%0.0%
Q2 2014$7,495,000
+4.1%
161,765
-7.7%
0.00%0.0%
Q1 2014$7,202,000
+3.2%
175,225
-4.2%
0.00%0.0%
Q4 2013$6,978,000
+62.9%
182,849
+2.0%
0.00%0.0%
Q3 2013$4,284,000
+37.0%
179,305
-2.6%
0.00%
+100.0%
Q2 2013$3,128,000184,0720.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Trigran Investments, Inc. 1,154,183$25,761,0003.00%
CAPITAL MANAGEMENT CORP /VA 275,130$6,141,0001.52%
Kent Lake Capital LLC 98,570$2,200,0001.21%
DIKER MANAGEMENT LLC 21,835$487,0000.60%
Portolan Capital Management 235,972$5,267,0000.53%
Riverwater Partners LLC 12,466$278,0000.28%
Ranger Investment Management 139,661$3,117,0000.24%
Invenomic Capital Management LP 144,287$3,220,0000.23%
CHATHAM CAPITAL GROUP, INC. 23,787$531,0000.12%
Teton Advisors, Inc. 22,000$491,0000.10%
View complete list of ANIKA THERAPEUTICS INC shareholders